PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22525275-0	2013	Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion.	Lenalidomide	0-12	MDM2 proto-oncogene	Homo sapiens	52-56	
22525275-4	2013	More importantly, we show that lenalidomide (Len) acts to stabilize MDM2, thereby accelerating p53 degradation.	Lenalidomide	31-43	MDM2 proto-oncogene	Homo sapiens	68-72	
22525275-4	2013	More importantly, we show that lenalidomide (Len) acts to stabilize MDM2, thereby accelerating p53 degradation.	Lenalidomide	45-48	MDM2 proto-oncogene	Homo sapiens	68-72	
25295231-11	2014	Through its inhibitory effect on PP2A, lenalidomide stabilizes MDM2 to restore p53 degradation in erythroid precursors, with subsequent arrest in G2/M.	Lenalidomide	39-51	MDM2 proto-oncogene	Homo sapiens	63-67